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therapy months ranged from $452–$921 for discontinued
patients and from $423–$483 for non-switched, contin-
ued patients. CONCLUSIONS: Patients who discontinued
SSRI therapy early tended to have higher costs than pa-
tients who continued therapy. It is unclear whether these
increased costs stem from treatment of medication side
effects or increased utilization related to lack of efficacy
of the initial antidepressant. Alternatively, early switchers
may simply be more clinically complex patients.
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OBJECTIVES: In France a large part of acute hospitalisa-
tion beds are occupied by long-term hospitalisation of
schizophrenic patients. A model was developed to com-
pare Intensive Case Management (ICM) to Standard Case
Management (SCM) for long-term hospitalised chronic
schizophrenic patients. METHODS: A model was used
to evaluate the number of patients that are either success-
fully dechronized, experiencing failure, or are readmitted
to hospital within a year for a cohort of 100 chronic
schizophrenic patients. With these figures, it was possible
to estimate the needs in terms of number of beds and em-
ployees in the catchment area of Clermont-Ferrand in
France, for the 1st, 2nd and 3rd year after the ICM strat-
egy have been implemented. RESULTS: At the beginning
of the first year, 100 hospitalisation beds, 30 nurses, 10
psychologists and 5 psychiatrists were needed. After 1
year these numbers were respectively reduced to 50, 15,
10 and 2.5 due to the success of the ICM strategy. This
positive trend is also recorded for the second year of im-
plementation. At the end of the 3rd year a steady point
level is nevertheless reached with the model, due to the
fact that there will always be patients that can not be
dechronized; the numbers at this point will be 11 beds, 3
nurses, 1 psychologist and a half-time psychiatrist. CON-
CLUSIONS: Due to the important caseload of ICM, it re-
mains more costly than SCM at implementation, but will
reduce cost from year 1, and be less costly than SCM
from year 3. This model can therefore evaluate the eco-
nomic impact of creating a dechronization unit in a
catchment area and make budgetary prevision for large-
scale implementation of ICM in France.
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BACKGROUND: It has been reported that approxi-
mately 1% of young women have anorexia nervosa and
4% bulimia. Managing eating disorders requires a multi-
disciplinary approach including acute hospitalization,
when necessary. This study was undertaken to assess the
cost of acute hospital care for these disorders. METH-
ODS: Inpatient cost estimates, adjusted for medical infla-
tion and cost-to-charge ratios, were developed using data
from all-payer 1998 discharge databases from five states,
supplemented with national fee schedules. ICD9 codes
were used to identify those with a principal diagnosis of
anorexia (307.1) or bulimia (307.51). Cases where both
diagnoses were coded are excluded from results reported
here. Log transformation was used to address highly
skewed distributions. Length-of-stay (LOS), disposition
and psychiatric unit care (PSYU) were also examined.
Hospital costs (i.e., accommodation, ancillary, physician)
are reported in 2000 US$. RESULTS: The state databases
yielded 641 cases of anorexia and 326 of bulimia. The
overwhelming majority (96%) were females. For anor-
exia: the mean age was 25 years (45% 20 years); mean
LOS was 13; 24% received care in a PSYU; 87% were
discharged home; 7% went to a rehab or mental health
facility (MHF) and 3% left against medical advice
(AMA). For bulimia, the mean age was 27 years (25%
20 years); mean LOS was 9; 39% received care in a
PSYU; 90% were discharged home; 4% to rehab or
MHF; 3% left AMA. The mean total cost per hospital
stay was $12,390 for anorexia and $9,120 for bulimia.
On average, the number of annual admissions was 1.6
and 1.2 for anorexia and bulimia, respectively. Managed
care was the largest primary payer. CONCLUSIONS: Al-
though hospitalization is not the primary site of medical
care for managing serious eating disorders, it’s sometimes
required. We believe that this information provides an es-
sential piece in understanding the economic consequences
of these conditions.
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OBJECTIVE: To estimate and compare the efficacy,
treatment-emergent adverse events, costs and outcomes
of olanzapine and ziprasidone for treatment of schizo-
phrenia. METHODS: A decision-analytic model was
used to determine outcomes for patients treated over a
1-year period. Model parameters were based on clinical
trial data and published medical literature. Data from
different trials were compared only when patient popula-
tions were similar. Comparative studies were available
for weight gain and cardiovascular events. For essential
parameters with no relevant study results, assumptions
were made that the medications would be similar. RE-
